News | May 12, 2026
Plus Therapeutics subsidiary clears key Medicare milestone
Paves way for CNS cancer test rollout
Paves way for CNS cancer test rollout
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
The Union Minister reviewed DST-supported SATHI-BHU facility
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Subscribe To Our Newsletter & Stay Updated
